v3 Template
V

VenomAid Diagnostics

Medtech / Biotechnology ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$1.8M
Funding Rounds
1
Last Funding
2024-01-30

About VenomAid Diagnostics

VenomAid Diagnostics is a medtech company focused on revolutionizing snakebite care globally. Their mission is to reduce the burden of snakebites by developing affordable diagnostic tools using state-of-the-art antibody discovery and venomics insights, empowering clinicians and bringing snakebite care into the 21st century.

Products & Services

Snake Venom Detection:A rapid test for detecting snake venom in clinical samples at the point of care, designed to be simple, affordable, and deployable.

Specialties

Snakebite Diagnostics Antibody Discovery Venomics Insights Affordable Diagnostic Technologies Point-of-Care Testing

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed
A: 1800000
MR: -
FA: $1.8 million
FAN: 1800000
D: 2024-01-30
FD: 2024-01-30
2 investors
Seed Latest
2024-01-30
$1.8M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Cecilie Knudsen

J

Jonas Arnold Jürgensen

A

Andreas Hougaard Laustsen-Kiel

Co-Founder

Recent News

VenomAid Diagnostics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Medtech / Biotechnology
Company Size
~30 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro